Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
ФГБУ Научный центр психического здоровья РАМН, Москва
Список исп. литературыСкрыть список 1. Волков В.П. Соматическая патология и причины смерти при шизофрении. Журн. неврол. и психиатр. им. С.С.Корсакова. 2009; 5: 14–9. 2. Гусева Л.Я. Смертность и причины смерти больных шизофренией. Дис. … канд. мед. наук. М., 1969. 3. Зильберштейн Х.Н., Гарбузенко Л.Л., Канторович В.И. Клинико-анатомическая характеристика шизофреника по материалам прозектуры УНИПНИ. В кн.: Тезисы и рефераты докладов 3-го съезда невропатологов и психиатров УССР. Харьков, 1959; с. 241–4. 4. Пятов М.Д. К вопросу о причинах смерти больных шизофренией. В кн.: Материалы к 13-й научной конференции аспирантов и клинических ординаторов 1-го ЛМИ им. И.П.Павлова. Л., 1965; с. 82–126. 5. Смулевич А.Б., Андрющенко А.В., Бескова Д.А. Психические расстройства в онкологии (результаты многоцентровой программы СИНТЕЗ). Психич. расстройства в общей медицине. 2009; 1: 4–11. 6. Abel KM, Allin MP, Jirtle AL. Schizophrenia, cancer and imprinting: early nutritional influences. Br J Psychiat 2006; 188: 394. 7. Ananth J, Burnstein M. Cancer: less common in psychiatric patients? Psychosomatics 1977; 18: 44–6. 8. Baldwin J. Schizophrenia and physical disease. Psychol Med 1979; 9: 611–8. 9. Baldwin J, Acheson ED, Graham WJ. Textbook of Medical Record Linkage Oxford: Oxford University Press 1987. 10. Bouza C, López-Cuadrado T, Amate JM. Physical disease in schizophrenia: a population-based analysis in Spain. BMC Public Health 2010; 10: 745. 11. Brown S, Kim M, Mitchell C, Inskip H. Twenty-five year mortality of a community cohort with schizophrenia. Br J Psychiat 2010; 196: 116–21. 12. Bushe C, Bradley A, Wildgust H, Hodgson R. Schizophrenia and breast cancer incidence. A systematic review of clinical studies. Schizophr Res 2009; 114: 6–16. 13. Catts VS, Catts SV. Apoptosis and schizophrenia: is the tumour suppressor gene, p53, a candidate susceptibility gene? Schizophr Res 2000; 41: 405–15. 14. Catts VS, Catts SV, O’Toole BI, Frost ADJ. Cancer incidence in patients with schizophrenia and their first-degree relatives – a meta-analysis. Acta Psychiat Scand 2008; 117: 323–36. 15. Cohen ME, Dembling B, Schorling JB. The association between schizophrenia and cancer: a population-based mortality study. Schizophr Res 2002; 57: 139–46. 16. Connolly BS, Barnett C, Vogt KN et al. A meta-analysis of published literature on waist-to-hip ratio and risk of breast cancer. Nutr Cancer 2002; 44: 127–38. 17. Cook MB, Akre O, Forman D et al. A systematic review and meta-analysis of perinatal variables in relation to the risk of testicular cancer – experiences of the mother. Int J Epidemiol 2009; 38: 1532–42. 18. Commissioners in Lunacy for England and Wales 1909. Ann Report London: HMSO (цит. по R.Hodgson и соавт., 2010). 19. Cui DH, Jiang KD, Jiang SD et al. The tumor suppressor adenomatous polyposis coli gene is associated with susceptibility to schizophrenia. Mol Psychiat 2005; 10: 669–77. 20. Dai Z, Xu YC, Niu L. Obesity and colorectal cancer risk: a meta-analysis of cohort studies. World J Gastroenterol 2007; 13: 4199–206. 21. Dalton SO, Laursen TM, Mellemkjær L et al. Risk for cancer in parents of patients with schizophrenia. Am J Psychiat 2004; 161: 903–8. 22. Dalton SO, Mellemkjaer L, Thomassen L et al. Risk for cancer in a cohort of patients hospitalized for schizophrenia in Denmark 1969–1993. Schizophr Res 2005; 75: 315–24. 23. Dupont A. Socio-psychiatric aspects of the young severely mentally retarded and the family. 19th Blake Marsh lecture delivered before the Royal College of Psychiatrists 1985. Br J Psychiat 1986; 148: 227–34. No abstr. available. 24. Fox BH, Howell MA. Cancer risk among psychiatric patients: a hypothesis. Int J Epidemiol 1974; 3: 207–8. 25. Goldacre MJ, Kurina LM, Wotton CJ et al. Schizophrenia and cancer: an epidemiological study. Br J Psychiat 2005; 187: 334–8. 26. Goulet K, Grignon S. Case report: clozapine given in the context of chemotherapy for lung cancer. Psychooncol 2008; 17 (5): 512–6. 27. Grinshpoon A, Barchana M, Ponizovsky A et al. Cancer in schizophrenia: is the risk higher or lower. Schizophr Res 2005; 73: 333–41. 28. Gulbinat W, Dupont A, Jablensky A et al. Cancer incidence of schizophrenic patients. Results of record linkage studies in three countries. Br J Psychiat 1992; 161 (Suppl. 18): 75–85. 29. Guo JJ. Schizophrenia associated with increased risk of colon cancer but reduced risk of respiratory cancer. Evid Based Ment Health 2008; 11 (3): 93. 30. Halbreich U, Palter S. Accelerated osteoporosis in psychiatric patients: possible pathophysiological processes. Schizophr Bull 1996; 22 (3): 447–54. Review. 31. Harvie M, Howell A, Vierkant RA et al. Association of gain and loss of weight before and after menopause with risk of postmenopausal breast cancer in the Iowa women’s health study. Cancer Epidemiol Biomark Prev 2005; 14: 656–61. 32. Hippisley-Cox J, Vinogradova Y, Coupland C, Parker C. Risk of malignancy in patients with schizophrenia or bipolar disorder: nested case-control study. Arch Gen Psychiat 2007; 64: 1368–76. 33. Hodgson R, Wildgust HJ, Bushe CJ. Cancer and schizophrenia: is there a paradox? J Psychopharmacol 2010; 24 (Suppl. 11): 51–60. 34. Hussar AE. Leading causes of death in institutionalized chronic schizophrenic patients: a study of 1275 autopsy protocols. J Nerv Ment Dis 1966; 142: 45–58. 35. Jablensky A, Lawrence D. Schizophrenia and cancer: is there a need to invoke a protective gene? Arch Gen Psychiat 2001; 58 (6): 579–80. 36. Jirtle RL. IGF2 loss of imprinting: a potential heritable risk factor for colorectal cancer. Gastroenterol 2004; 126: 1190–201. 37. Kampert JB, Blair SN, Barlow CE. Physical activity, physical fitness, and all-cause and cancer mortality: a prospective study of men and women. Ann Epidemiol 1996; 6: 452–7. 38. Kelly C, McCreadie RG. Smoking habits, current symptoms and premorbid characteristics of schizophrenic patients in Nithsdale, Scotland. Am J Psychiat 1999; 156: 1751–7. 39. Kemppainen L, Veijola J, Jokelainen J, Hartikainen A-L. Birth order and risk for schizophrenia: a 31-year follow-up of the Northern Finland 1966 Birth Cohort. Acta Psychiat Scand 2001; 104: 148–52. 40. Leucht S, Burkard T, Henderson J et al. Physical illness and schizophrenia: a review of the literature. Acta Psychiat Scand 2007; 116 (5): 317–33. 41. Lichtermann D, Ekelund J, Pukkala E et al. Incidence of cancer among persons with schizophrenia and their relatives. Arch Gen Psychiat 2001; 58: 573–8. 42. McCreadie RG, McDonald E, Blacklock C et al. Dietary intake of schizophrenic patients in Nithsdale, Scotland: case-control study. Br Med J 1998; 317: 784–5. 43. Mortensen PB. The incidence of cancer in schizophrenic patients. J Epidem Commun Health 1989; 43: 43–7. 44. Mortensen PB. The occurrence of cancer in first-admitted schizophrenic patients. Schizophr Res 1994; 12: 185–94. 45. Office for National Statistics Cancer Statistics Registrations: Registrations of Cancer Diagnosed in 2004, England. Series MB1 no. 35 London: Office for National Statistics 2007. 46. Osterlind A. Malignant melanoma in Denmark: occurrence and risk factors. Acta Oncol 1990; 29: 833–54. 47. Park JK, Lee HJ, Kim JW et al. Differences in p53 gene polymorphisms between Korean schizophrenia and lung cancer patients. Schizophr Res 2004; 67: 71–4. 48. Parker ED, Folsom AR. Intentional weight loss and incidence of obesity-related cancers: the Iowa Women’s Health Study. Int J Obes Relat Metab Disord 2003; 27: 1447–52. 49. Punnoose, Belgamwar MR. Nicotine for schizophrenia. Cochrane Database Syst Rev 2006; 1: CD004838. 50. Rosenthal D. The spectrum concept in schizophrenic and manic-depressive disorders. Res Publ Assoc Res Nerv Ment Dis 1975; 54: 19–25. 51. Seeman MV. Preventing breast cancer in women with schizophrenia. Acta Psychiat Scand 2011; 123 (2): 107–17. 52. Smith S, Yeomans D, Bushe CJ et al. A well-being programme in severe mental illness. Reducing risk for physical ill-health: a post-programme service evaluation at 2 years. Eur Psychiat 2007; 22: 413–8. 53. Spector LG, Puumala SE, Carozza SE, Chow EJ. Cancer risk among children with very low birth weights. Pediatrics 2009; 124: 96–104. 54. Tandon R, Keshavan MS, Nasrallah HA. Schizophrenia, «Just the facts». What we know in 2008. 2. Epidemiology and etiology. Schizoprenia research 2008; 102: 1–18. 55. Thakore JH. Metabolic disturbance in first-episode schizophrenia. Br J Psychiat 2004; 47: s76–9. 56. Torrey EF. Prostate cancer and schizophrenia. Urology 2006; 68 (6): 1280–3. 57. Tran E, Rouillon F, Loze JY et al. Cancer mortality in patients with schizophrenia: an 11-year prospective cohort study. Cancer 2009; 115: 3555–62. 58. Waterland RA, Jirtle RL. Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases. Nutrition 2004; 20 (1): 63–8. 59. Yang Y, Xiao Z, Chen W et al. Tumor suppressor gene TP53 is genetically associated with schizophrenia in the Chinese population. Neurosci Lett 2004; 369: 126–31.